OTC Markets EXMKT - Delayed Quote USD

RespireRx Pharmaceuticals Inc. (RSPI)

Compare
0.0008
0.0000
(0.00%)
At close: January 10 at 3:00:00 PM EST
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2022
12/31/2021
12/31/2020
Operating Expense
1,407.8480
1,579.3550
2,559.1280
3,315.1350
Operating Income
-1,407.8480
-1,579.3550
-2,559.1280
-3,315.1350
Net Non Operating Interest Income Expense
-435.7350
-603.8180
-724.7690
-545.6750
Other Income Expense
47.2970
80.4530
139.0570
-440.4010
Pretax Income
-1,796.2860
-2,102.7200
-3,144.8400
-4,301.2110
Net Income Common Stockholders
-2,170.6540
-3,972.9930
-3,522.8820
-5,741.4250
Diluted NI Available to Com Stockholders
-2,170.6540
-3,972.9930
-3,522.8820
-5,741.4250
Basic EPS
-0.02
-0.04
-0.04
-0.02
Diluted EPS
-0.02
-0.04
-0.04
-0.02
Basic Average Shares
173,891.7280
111,322.7420
88,347.2060
258,556.6400
Diluted Average Shares
173,891.7280
111,322.7420
88,347.2060
258,556.6400
Total Operating Income as Reported
-1,407.8480
-1,579.3550
-2,559.1280
-3,315.1350
Total Expenses
1,407.8480
1,579.3550
2,559.1280
3,315.1350
Net Income from Continuing & Discontinued Operation
-1,796.2860
-2,102.7200
-3,144.8400
-4,301.2110
Normalized Income
-1,914.7440
-2,254.3340
-3,283.8970
-3,860.8100
Interest Expense
435.7350
603.8180
724.7690
545.6750
Net Interest Income
-435.7350
-603.8180
-724.7690
-545.6750
EBIT
-1,360.5510
-1,498.9020
-2,420.0710
-3,755.5360
EBITDA
-1,360.5510
-1,498.9020
-2,420.0710
-3,755.5360
Net Income from Continuing Operation Net Minority Interest
-1,796.2860
-2,102.7200
-3,144.8400
-4,301.2110
Total Unusual Items Excluding Goodwill
118.4580
151.6140
139.0570
-440.4010
Total Unusual Items
118.4580
151.6140
139.0570
-440.4010
Normalized EBITDA
-1,479.0090
-1,650.5160
-2,559.1280
-3,315.1350
12/31/2020 - 11/6/1989

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

GSTC GlobeStar Therapeutics Corporation
0.0004
+16.67%
 
NBIO Nascent Biotech, Inc.
0.0600
+42.81%
 
MRES Institute of Biomedical Research Corp.
0.0230
+74.24%
 
ESLAW Estrella Immunopharma, Inc.
0.0910
-0.11%
 
OTLC Oncotelic Therapeutics, Inc.
0.0300
0.00%
 
SBMFF Sino Biopharmaceutical Limited
0.4110
0.00%
 
HALB Halberd Corporation
0.0043
+16.22%
 
INTI Inhibitor Therapeutics, Inc.
0.0670
+11.67%
 
MBXBF Microbix Biosystems Inc.
0.2980
+0.07%
 
MRZM Marizyme, Inc.
0.0041
-14.58%